Dexalev Ophthalmic Solution is a new fixed dose combination (FDC) of levofloxacin and dexamethasone offers only 7-days therapy than other combinations of topical antibiotic/corticosteroid. It is indicated for the treatment of eye infections caused by susceptible microorganisms and in the prevention of inflammation and bacterial infection that may occur after ocular surgery. In the meantime, Levofloxacin is a fluoroquinolone antibacterial agent, has a wide spectrum of activities against different gram-positive microorganisms (e.g. S. aureus MSSA, S. pyogenes, S. pneumoniae, viridans group streptococci), aerobic Gram-negative bacteria (e.g. E. coli, H. influenzae, M. catarrhalis, P. aeruginosa community isolates), other organisms (e.g. Chlamydia trachomatis). Beside this Dexalev is manufactured with European raw material from Spain.
FR
DE